Download PDF
Thromb Haemost 1970; 23(02): 306-312
DOI: 10.1055/s-0038-1654144
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

The Preparation of an Artificial Reagent for the One-Stage Factor VIII Assay

D Nyman
1   Blood Coagulation and Fibrinolysis Laboratory (Head: Dr. F. Duckert) of the University Department of Medicine (Head: Prof .Dr. F. Koller), Bürgerspital Basel, Switzerland
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

A method for preparation of an artificial substrate for the one-stage factor VIII assay is described. Standardization of the test is given. The method is specific and reproducible.

 

  • References

  • 1 Bachmann F, Duckert F, Koller F. The Stuart-Prower Factor Assay and its Clinical Significance. Thrombos. Diathes. haemorrh. (Stuttg.) 2: 24 1958;
    PubMedGoogle Scholar
  • 2 Baumgarten W, Sanders B. E, Belkin B. D, Pagenkemper F. E, Alkers W. G, Gimi-nera J. L. Antihemophilic Factor : Its Presence in Fibrinogen, Assay Problems and the Stability of Lyophilized AHF-Fibrinogen Preparations. Thrombos. Diathes. haemorrh. (Stuttg.) 9: 354 1963;
    PubMedGoogle Scholar
  • 3 Bell W. N, Alton H. G. A Brain Extract as a Substitute for Platelets Suspensions in the Thromboplastin Generation Test. Nature (Lond.) 174: 880 1954;
    CrossrefPubMedGoogle Scholar
  • 4 Blombäck B, Blombäck M. Purification of human and bovine fibrinogen. Ark. Kemi 10: 415 1956;
    PubMedGoogle Scholar
  • 5 Bounameaux Y. Dosage du facteur VIII en un temps. Acta haemat. (Basel) 17: 355 1957;
    CrossrefPubMedGoogle Scholar
  • 6 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta haemat. (Basel) 17: 237 1957;
    CrossrefPubMedGoogle Scholar
  • 7 Das K. G, Aikat B. K. A Method for the Assay of Factor VIII with Haemophilic Plasma. Ind. J. med. Res 54: 1138 1966;
    PubMedGoogle Scholar
  • 8 Davidson E, Tomlin S. ‘Thrombocytopenic Serum’ : An artificial factor VIII-deficient reagent. J. elm. Path 17: 188 1964;
    PubMedGoogle Scholar
  • 9 Didisheim P. An artificial reagent for the diagnosis of classical haemophilia. Science 129: 389 1959;
    CrossrefPubMedGoogle Scholar
  • 10 Hardisty R. M, Macpherson J. G. A one-stage factor VIII (antihemophilic globuline) assay and its use on venous and capillary plasma. Thrombos. Diathes. haemorrh. (Stuttg.) 7: 215 1962;
    PubMedGoogle Scholar
  • 11 Hjort P, Rapaport S. I, Owren P. A. A Simple, Specific One-stage Prothrombin Assay Using Russell’s Viper Venom in Cephalin Suspension. J. Lab. clin. Med 46: 89 1955;
    PubMedGoogle Scholar
  • 12 Ingram G. I. G. Blood Coagulation, Factor VIII: Genetics, Physiological Control, Bioassay. Advanc. clin. Chem 8: 222 1965;
    PubMedGoogle Scholar
  • 13 Jung E. G. A Rapid Quantitative Assay of Factor VIII (AHG) without the Use of Haemophilia A Plasma. Thrombos. Diathes. haemorrh. (Stuttg.) 4: 323 1960;
    PubMedGoogle Scholar
  • 14 Kappeler R. Das Verhalten von Faktor V im Serum unter normalen und pathologischen Bedingungen. Klin. Med 153: 103-113 1955;
    PubMedGoogle Scholar
  • 15 Koller F, Loeliger A, Duckert F. Experiments on a new clotting factor (Factor VII). Acta haemat. (Basel) 6: 1 1951;
    CrossrefPubMedGoogle Scholar
  • 16 Margolis J. The kaolin clotting time. J. clin. Path 11: 406 1958;
    CrossrefPubMedGoogle Scholar
  • 17 Milstone J. H. The Problem of the Lipid Thromboplastin. Yale J. Biol. Med 22: 675 1950;
    PubMedGoogle Scholar
  • 18 Nossei H. L. The Contact Phase of Blood Coagulation. Blackwell Scientific Publications; Oxford: 1964
    Google Scholar
  • 19 Pool J. G, Robinson J. Assay of Plasma Antihaemophilic Globulin (AHG). Brit. J. Haemat 5: 17 1959;
    CrossrefPubMedGoogle Scholar
  • 20 Pudlak P, Deimlova E. Quantitative Assay of Factor VIII (AHG) Using the Thrombin Generation Test. Brit. J. Haemat 12: 409 1966;
    CrossrefPubMedGoogle Scholar
  • 21 Schnitger H. Entwicklung eines neuartigen Gerätes zur automatischen Registrierung von Blutgerinnungszeiten und kritischer Beitrag zur Theorie anderer Meßprinzipien für gerinnungsphysiologische Untersuchungen. Thesis. Marburg (1956).
    PubMedGoogle Scholar
  • 22 Stapp W. F. The Use of DEAE Cellulose in the Preparation of a Factor VIII (AHG)-free Bovine Fibrinogen Reagent. Thrombos. Diathes. haemorrh. (Stuttg.) 7: 287 1961;
    PubMedGoogle Scholar
  • 23 Stormoken H. Reactivity of stored plasma to thrombin, with reference to the fibrinogen conversion accelerator and heparinoid activity. Brit. J. Haemat 3: 299 1957;
    CrossrefPubMedGoogle Scholar
  • 24 Triantaphyllopoulos D. G, Quick A. J, Greenwalt T. J. Action of disodiumethylenediamine-tetraacetate on blood coagulation. Evidence of the development of heparinoid activity during incubation or aeration of plasma. Blood 10: 534 1955;
    PubMedGoogle Scholar
  • 25 Veder H. A. Further Purification of the Antihaemophilic Factor (AHF). Thrombos. Diathes. haemorrh. (Stuttg.) 16: 738 1966;
    PubMedGoogle Scholar
  • 26 Veltkamp J. J, Orion E. F, Loeliger E. A. Detection of the Carrier State in Hereditary Coagulation Disorders. Thrombos. Diathes. haemorrh. (Stuttg.) 19: 279 1968;
    PubMedGoogle Scholar
  • 27 Vinazzer H. Eine einfache quantitative Methode zur Bestimmung des Faktor VIII. Thrombos. Diathes. haemorrh. (Stuttg.) 18: 386 1967;
    PubMedGoogle Scholar
  • 28 Waaler B. A. Contact activation in the intrinsic blood clotting system. Med. Diss. University Press; Oslo: 1959
    Google Scholar
  • 29 Wolf P. Assay of Antihaemophilic Factor using the Prothrombin Conversion Ratio. Brit. J. Haemat 2: 386 1956;
    CrossrefPubMedGoogle Scholar